The report "Pharmaceutical Blister Packaging Market by Material (Plastic Films, Aluminum Foils, Paper & Paperboard), Blister Type, Sealing Technology, Structure Type, Drug Type, Functionality, Application, End User, and Region - Global Forecast to 2030" is projected to grow from USD 28.7 billion in 2025 to USD 61.4 billion by 2030, at a CAGR of 16.5% during the forecast period.
Browse 160 market data Tables and 50 Figures spread through 227 Pages and in-depth TOC on "Pharmaceutical Blister Packaging Market, By Material (Plastic Films, Aluminum Foils, Paper & Paperboard), Blister Type, Sealing Technology, Structure Type, Drug Type, Functionality, Application, End User, and Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-blister-packaging-market-71919874.html
The pharmaceutical blister packaging market has experienced notable growth, driven by the rising demand for oral solid drugs and the convenience and safety features that blister packaging offers. These solutions provide patients with effective protection against moisture, UV rays, and contamination while ensuring child-resistant and tamper-evident features. Furthermore, the rise of self-administered drug delivery systems has attracted significant attention for addressing challenges in the pharmaceutical blister packaging market. The growing occurrence of chronic diseases and an aging population continue to drive demand. On a positive note, innovative developments in packaging technologies and the adoption of PVC-free blisters and recyclable packaging solutions are likely to enhance sustainability and drive overall growth in the pharmaceutical blister packaging market.
The Asia Pacific region is expected to witness the highest growth in the pharmaceutical blister packaging market through 2030.
The pharmaceutical blister packaging market is segmented into North America, Europe, Asia Pacific, and other regions. Among these, the Asia Pacific is expected to witness the highest growth, at a CAGR of 18.5% from 2025 to 2030, reaching USD 20.3 billion by 2030. This rapid expansion is driven by increasing healthcare infrastructure development, rising pharmaceutical manufacturing activities, and growing demand for convenient packaging solutions. The region's large patient population and increasing prevalence of chronic diseases have significantly contributed to market growth. Additionally, the rising demand for cost-effective and protective packaging solutions has further propelled the expansion of the pharmaceutical blister packaging market, particularly in the Asia Pacific region.
In 2025, the thermoformed blisters segment accounted for a significant share of the pharmaceutical blister packaging market.
Thermoformed blister packaging represents the largest segment in pharmaceutical blister packaging because it provides cost-effective production solutions that manufacturers can scale and use creative design methods. The process requires heating plastic films, which include PVC PET and PP to create specific shapes that designers use to produce their automated manufacturing systems that package single doses of medicine. Thermoformed blisters account for over 65% of the blister packaging market, reflecting their widespread adoption across pharmaceutical applications. The packaging solution maintains dominance because it provides multiple benefits, including lower material expenses compared to cold-form aluminum, complete product visibility, the ability to package various medicine types, and its capacity to meet regulatory standards for tamper-evidence and patient compliance. Thermoformed blisters serve as the worldwide standard for solid oral dosage forms because they provide a perfect combination of product protection at low costs and allow manufacturers to create large quantities of their products.
The key players in the pharmaceutical blister packaging market include Amcor Plc (Switzerland), Constantia Flexibles (Austria), Tekni-Plex (US), Sonoco Products Company (US), UFlex Ltd. (India), Winpak Ltd. (Canada), ACG (India), WestRock (US), Honeywell International (US), and other leading manufacturers, making substantial investments in research and development and strategic collaborations to advance packaging technologies.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com